Serafio-Gómez José Luis, Aragón-Quintana César, Bustillos-Ponce Melanie, Varela-Barraza Omar, Silva Beatriz
General Surgery, Chihuahua City General Hospital "Dr. Salvador Zubirán Anchondo", Chihuahua, MEX.
General Medicine, Chihuahua City General Hospital "Dr. Salvador Zubirán Anchondo", Chihuahua, MEX.
Cureus. 2023 Nov 17;15(11):e48967. doi: 10.7759/cureus.48967. eCollection 2023 Nov.
Introduction Giant ventral hernias are a surgical challenge due to their size and the need for a specialized approach during repair. Over the decades, abdominal wall surgery has evolved into a sophisticated field with a wide range of techniques aimed at improving patient outcomes. However, there is no universally accepted method suitable for repairing all giant ventral hernias. Surgeons must rely on a combination of techniques, choosing the approach that best matches their expertise, available resources, and the individual patient's specific needs. This article explores the effective use of a combination of techniques, including preoperative botulinum toxin application, modified Ramírez's component separation, and Rives-Stoppa hernioplasty, yielding excellent results and minimizing recurrences. Objective This study aims to provide a comprehensive literature review of giant ventral hernias. Additionally, we aim to share our experience in managing and repairing giant ventral hernias using a multi-modal approach, combining various surgical techniques with a focus on patient safety, reduced recurrence rates, and improved quality of life. Methods Between October 1, 2019, and October 1, 2021, six patients with giant ventral hernias were enrolled at our department of surgery. They received preoperative botulinum toxin A (BT) application, underwent corrective surgery involving modified component separation following the Ramírez method, and received Rives-Stoppa hernioplasty. Follow-up was conducted for at least six months. Results Six patients were included in the study: three women and three men. They had an average age of 53.6 years and an average body mass index of 31.8 kg/m. The most common location of the hernia defect was supra and infraumbilical, among 66% of cases. The primary adverse effect associated with BT application was abdominal distension, reported in 33% of patients. No postoperative complications, such as abscesses or seromas, were observed. After the surgical procedure, the average hospital stay was 2.6 days, and no recurrences were noted within six months post-surgery. Conclusion The proposed method, which involves a combination of techniques, has demonstrated promising results based on our experience. However, to solidify these findings and better understand the full scope of this approach, further comprehensive statistical studies involving larger populations are essential. These studies will not only validate our results but also provide valuable insights for optimizing the management of giant ventral hernias.
引言
巨大腹疝因其大小以及修复过程中需要特殊方法而成为外科手术的一项挑战。几十年来,腹壁外科已发展成为一个复杂的领域,有多种旨在改善患者预后的技术。然而,目前尚无一种普遍接受的方法适用于修复所有巨大腹疝。外科医生必须依靠多种技术的组合,选择最符合其专业技能、可用资源以及个体患者特定需求的方法。本文探讨了术前应用肉毒杆菌毒素、改良的拉米雷斯(Ramírez)成分分离术和里夫斯 - 斯托帕(Rives - Stoppa)疝修补术等技术组合的有效应用,取得了优异的效果并减少了复发。
目的
本研究旨在对巨大腹疝进行全面的文献综述。此外,我们旨在分享使用多模式方法管理和修复巨大腹疝的经验,该方法结合了各种手术技术,重点关注患者安全、降低复发率和改善生活质量。
方法
在2019年10月1日至2021年10月1日期间,我们外科收治了6例巨大腹疝患者。他们接受了术前肉毒杆菌毒素A(BT)注射,采用改良的拉米雷斯方法进行成分分离的矫正手术,并接受了里夫斯 - 斯托帕疝修补术。随访至少6个月。
结果
6例患者纳入研究,其中3名女性和3名男性。他们的平均年龄为53.6岁,平均体重指数为31.8kg/m²。疝缺损最常见的部位是脐上和脐下,占66%的病例。与应用BT相关主要不良反应是腹胀,33%的患者报告有此症状。未观察到术后并发症,如脓肿或血清肿。手术后,平均住院时间为2.6天,术后6个月内未发现复发。
结论
根据我们的经验,所提出的技术组合方法已显示出有前景的结果。然而,为了巩固这些发现并更好地理解该方法的全貌,有必要进行涉及更大样本量的进一步全面统计研究。这些研究不仅将验证我们的结果,还将为优化巨大腹疝的管理提供有价值的见解。